TW226022B - - Google Patents
Info
- Publication number
- TW226022B TW226022B TW080103367A TW80103367A TW226022B TW 226022 B TW226022 B TW 226022B TW 080103367 A TW080103367 A TW 080103367A TW 80103367 A TW80103367 A TW 80103367A TW 226022 B TW226022 B TW 226022B
- Authority
- TW
- Taiwan
- Prior art keywords
- csf
- ser
- residue
- derivatives
- naturally occurring
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
- C12N15/68—Stabilisation of the vector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/14—Lymphokine; related peptides
- Y10S930/145—Colony stimulating factor
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909009623A GB9009623D0 (en) | 1990-04-30 | 1990-04-30 | Polypeptides |
GB909013773A GB9013773D0 (en) | 1990-06-20 | 1990-06-20 | Polypeptides |
GB909016215A GB9016215D0 (en) | 1990-07-24 | 1990-07-24 | Polypeptides |
GB919102799A GB9102799D0 (en) | 1991-02-11 | 1991-02-11 | Polypeptides |
GB919107846A GB9107846D0 (en) | 1990-04-30 | 1991-04-12 | Polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
TW226022B true TW226022B (zh) | 1994-07-01 |
Family
ID=27450502
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW080103367A TW226022B (zh) | 1990-04-30 | 1991-04-30 |
Country Status (22)
Country | Link |
---|---|
US (1) | US5416195A (zh) |
EP (1) | EP0459630B1 (zh) |
JP (1) | JPH06100593A (zh) |
KR (1) | KR910018406A (zh) |
AT (1) | ATE169336T1 (zh) |
AU (1) | AU644647B2 (zh) |
CA (1) | CA2041454A1 (zh) |
CS (1) | CS125091A3 (zh) |
DE (1) | DE69129927T2 (zh) |
DK (1) | DK0459630T3 (zh) |
ES (1) | ES2118737T3 (zh) |
FI (1) | FI912086A (zh) |
GB (1) | GB9107846D0 (zh) |
GR (1) | GR3027590T3 (zh) |
HU (1) | HUT60769A (zh) |
IE (1) | IE911440A1 (zh) |
IL (1) | IL97993A0 (zh) |
NO (1) | NO911696L (zh) |
NZ (1) | NZ237974A (zh) |
PT (1) | PT97529A (zh) |
TW (1) | TW226022B (zh) |
ZW (1) | ZW4891A1 (zh) |
Families Citing this family (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5718893A (en) * | 1984-04-15 | 1998-02-17 | Foster; Preston F. | Use of G-CSF to reduce acute rejection |
IE912365A1 (en) * | 1990-07-23 | 1992-01-29 | Zeneca Ltd | Continuous release pharmaceutical compositions |
US5581476A (en) | 1993-01-28 | 1996-12-03 | Amgen Inc. | Computer-based methods and articles of manufacture for preparing G-CSF analogs |
AU7795094A (en) * | 1993-09-15 | 1995-04-03 | New York University | Dna sequence which binds transcriptional regulatory proteins activated in response to various cytokines and uses thereof |
US5536495A (en) * | 1994-04-15 | 1996-07-16 | Foster; Preston F. | Use of G-CSF to reduce acute rejection |
US20030053982A1 (en) | 1994-09-26 | 2003-03-20 | Kinstler Olaf B. | N-terminally chemically modified protein compositions and methods |
US5573911A (en) * | 1994-10-03 | 1996-11-12 | Lifecodes Corp. | Methods and materials for detecting autoimmune antibodies |
US5824784A (en) | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
IT1285405B1 (it) * | 1995-06-06 | 1998-06-03 | Alza Corp | Modificazione di farmaci polipeptidici per accrescere il flusso per elettrotrasporto. |
KR100440460B1 (ko) * | 1998-07-08 | 2004-10-08 | 주식회사유한양행 | 인체 과립구 콜로니 자극인자의 유전자, 재조합 벡터 및 형질 전환체 및 그들을 이용한 인체 과립구 콜로니 자극인자의 제조방법 |
US6245740B1 (en) | 1998-12-23 | 2001-06-12 | Amgen Inc. | Polyol:oil suspensions for the sustained release of proteins |
US7208473B2 (en) * | 1999-01-06 | 2007-04-24 | Xencor, Inc. | Nucleic acids and protein variants of hG-CSF with granulopoietic activity |
US6627186B1 (en) | 1999-01-06 | 2003-09-30 | Xencor | Nucleic acids and protein variants of hG-CSF with granulopoietic activity |
KR100356140B1 (ko) * | 1999-07-08 | 2002-10-19 | 한미약품공업 주식회사 | 인간 과립구 콜로니 자극인자 변이체 및 이의 생산 방법 |
US6831158B2 (en) * | 2000-01-10 | 2004-12-14 | Maxygen Holdings Ltd. | G-CSF conjugates |
US6646110B2 (en) * | 2000-01-10 | 2003-11-11 | Maxygen Holdings Ltd. | G-CSF polypeptides and conjugates |
US6555660B2 (en) * | 2000-01-10 | 2003-04-29 | Maxygen Holdings Ltd. | G-CSF conjugates |
KR100408429B1 (ko) * | 2000-01-24 | 2003-12-06 | 한미약품 주식회사 | 유즙 중에 인간 과립구 콜로니 자극인자를 생산하는형질전환 흑염소 |
ES2220673T3 (es) | 2000-02-29 | 2004-12-16 | Pfizer Products Inc. | Factor estimulante de colonias de granulocitos estabilizado. |
US8435939B2 (en) | 2000-09-05 | 2013-05-07 | Biokine Therapeutics Ltd. | Polypeptide anti-HIV agent containing the same |
US7030218B2 (en) | 2000-09-08 | 2006-04-18 | Gryphon Therapeutics | Pseudo native chemical ligation |
US7118737B2 (en) | 2000-09-08 | 2006-10-10 | Amylin Pharmaceuticals, Inc. | Polymer-modified synthetic proteins |
DK1317537T3 (da) | 2000-09-08 | 2007-04-30 | Massachusetts Inst Technology | Sammensætninger og fremgangsmåder med G-CSF analoger |
US7430476B2 (en) | 2001-02-19 | 2008-09-30 | Merck Patent Gmbh | Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity |
JP4444652B2 (ja) * | 2001-07-11 | 2010-03-31 | マキシゲン・ホールディングズ・リミテッド | G−csf結合体 |
US7173003B2 (en) | 2001-10-10 | 2007-02-06 | Neose Technologies, Inc. | Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
US7214660B2 (en) | 2001-10-10 | 2007-05-08 | Neose Technologies, Inc. | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
DK2279755T3 (da) | 2001-10-10 | 2014-05-26 | Ratiopharm Gmbh | Remodellering og glycokonjugering af fibroblastvækstfaktor (FGF) |
ES2606840T3 (es) | 2001-10-10 | 2017-03-28 | Ratiopharm Gmbh | Remodelación y glicoconjugación de factor estimulante de colonias de granulocitos (G-CSF) |
WO2003078461A1 (en) | 2002-03-20 | 2003-09-25 | Biopolymed Inc. | Preparation of g-csf stoichiometrically conjugated with biocompatible polymers at cystein residue |
EP1541585B1 (en) | 2002-08-27 | 2013-01-30 | Biokine Therapeutics Ltd. | Cxcr4 antagonist and use thereof |
ATE466085T1 (de) * | 2002-09-09 | 2010-05-15 | Hanall Pharmaceutical Co Ltd | Protease-resistente modifizierte interferon alpha polypeptide |
US7695723B2 (en) | 2002-12-31 | 2010-04-13 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
US7785601B2 (en) | 2002-12-31 | 2010-08-31 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
CA2519092C (en) | 2003-03-14 | 2014-08-05 | Neose Technologies, Inc. | Branched water-soluble polymers and their conjugates |
US20070026485A1 (en) | 2003-04-09 | 2007-02-01 | Neose Technologies, Inc. | Glycopegylation methods and proteins/peptides produced by the methods |
WO2006127896A2 (en) | 2005-05-25 | 2006-11-30 | Neose Technologies, Inc. | Glycopegylated factor ix |
US8791070B2 (en) | 2003-04-09 | 2014-07-29 | Novo Nordisk A/S | Glycopegylated factor IX |
WO2005012484A2 (en) | 2003-07-25 | 2005-02-10 | Neose Technologies, Inc. | Antibody-toxin conjugates |
US8338373B2 (en) * | 2003-10-24 | 2012-12-25 | Nora Therapeutics, Inc. | Method for reducing the risk of spontaneous abortion in a human female subject |
DK2441465T3 (da) * | 2003-10-24 | 2014-04-14 | Nora Therapeutics Inc | Præparater og fremgangsmåder til en sund graviditet |
US20090226397A1 (en) * | 2003-10-24 | 2009-09-10 | Nora Therapeutics, Inc. | Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination |
US7220407B2 (en) | 2003-10-27 | 2007-05-22 | Amgen Inc. | G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction |
US8633157B2 (en) | 2003-11-24 | 2014-01-21 | Novo Nordisk A/S | Glycopegylated erythropoietin |
US20080305992A1 (en) | 2003-11-24 | 2008-12-11 | Neose Technologies, Inc. | Glycopegylated erythropoietin |
US20060040856A1 (en) | 2003-12-03 | 2006-02-23 | Neose Technologies, Inc. | Glycopegylated factor IX |
ES2560657T3 (es) | 2004-01-08 | 2016-02-22 | Ratiopharm Gmbh | Glicosilación con unión en O de péptidos G-CSF |
WO2006010143A2 (en) | 2004-07-13 | 2006-01-26 | Neose Technologies, Inc. | Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1] |
DK2586456T3 (en) | 2004-10-29 | 2016-03-21 | Ratiopharm Gmbh | Conversion and glycopegylation of fibroblast growth factor (FGF) |
WO2006055260A2 (en) | 2004-11-05 | 2006-05-26 | Northwestern University | Use of scf and g-csf in the treatment of cerebral ischemia and neurological disorders |
JP4951527B2 (ja) | 2005-01-10 | 2012-06-13 | バイオジェネリックス アーゲー | 糖peg化顆粒球コロニー刺激因子 |
US20070154992A1 (en) | 2005-04-08 | 2007-07-05 | Neose Technologies, Inc. | Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
WO2006128460A2 (en) | 2005-06-01 | 2006-12-07 | Maxygen Holdings Ltd. | Pegylated g-csf polypeptides and methods of producing same |
KR100694994B1 (ko) * | 2005-06-13 | 2007-03-14 | 씨제이 주식회사 | 사람 과립구 콜로니 형성인자 동종체 |
US20070105755A1 (en) | 2005-10-26 | 2007-05-10 | Neose Technologies, Inc. | One pot desialylation and glycopegylation of therapeutic peptides |
US20090048440A1 (en) | 2005-11-03 | 2009-02-19 | Neose Technologies, Inc. | Nucleotide Sugar Purification Using Membranes |
DK1994138T3 (da) * | 2006-03-06 | 2014-05-12 | Cadila Healthcare Ltd | Fremgangsmåde til fremstilling af humant g-csf |
WO2008011633A2 (en) | 2006-07-21 | 2008-01-24 | Neose Technologies, Inc. | Glycosylation of peptides via o-linked glycosylation sequences |
US8969532B2 (en) | 2006-10-03 | 2015-03-03 | Novo Nordisk A/S | Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography |
ES2842210T3 (es) | 2006-12-21 | 2021-07-13 | Biokine Therapeutics Ltd | 4F-benzoil-TN14003 para la movilización de células progenitoras hematopoyéticas con vistas al trasplante |
CA2682897C (en) | 2007-04-03 | 2016-11-22 | Biogenerix Ag | Methods of treatment using glycopegylated g-csf |
MX2009013259A (es) | 2007-06-12 | 2010-01-25 | Novo Nordisk As | Proceso mejorado para la produccion de azucares de nucleotidos. |
AU2008287063B2 (en) | 2007-08-09 | 2013-10-24 | Genzyme Corporation | Method of treating autoimmune disease with mesenchymal stem cells |
AU2008292186B9 (en) | 2007-08-27 | 2014-07-03 | Ratiopharm Gmbh | Liquid formulation of G-CSF conjugate |
US8758761B2 (en) | 2007-09-30 | 2014-06-24 | University Of Florida Research Foundation, Inc. | Combination therapies for treating type 1 diabetes |
CN103694337B (zh) | 2008-02-08 | 2016-03-02 | Ambrx公司 | 经修饰瘦素多肽和其用途 |
PL2257311T3 (pl) | 2008-02-27 | 2014-09-30 | Novo Nordisk As | Koniugaty cząsteczek czynnika VIII |
EP2274325A4 (en) * | 2008-05-13 | 2011-05-25 | Nora Therapeutics Inc | ANALOGUE OF HUMAN G-CSF AND METHOD OF MANUFACTURE AND APPLICATION THEREOF |
CN102223893B (zh) | 2008-07-22 | 2014-07-16 | 曼诺吉尼克斯公司 | 治疗与绝经、激素改变和关节炎相关的症状的组合物和方法 |
EP3225248B1 (en) * | 2008-07-23 | 2023-06-07 | Ambrx, Inc. | Modified bovine g-csf polypeptides and their uses |
US9151289B2 (en) | 2008-08-21 | 2015-10-06 | Cummins Inc. | Fuel pump |
US9155780B2 (en) | 2009-02-11 | 2015-10-13 | Yeda Research And Development Co. Ltd. | Short beta-defensin-derived peptides |
ES2462517T3 (es) | 2009-06-14 | 2014-05-23 | Biokine Therapeutics Ltd. | Terapia con péptidos para aumentar los niveles de plaquetas |
TWI409082B (zh) | 2010-01-19 | 2013-09-21 | Hanmi Science Co Ltd | 用於長效型粒細胞集落刺激因子(g-csf)共軛物之液態劑型 |
CA2791361C (en) | 2010-03-04 | 2018-06-12 | Pfenex Inc. | Method for producing soluble recombinant interferon protein without denaturing |
EP2552949B1 (en) | 2010-04-01 | 2016-08-17 | Pfenex Inc. | Methods for g-csf production in a pseudomonas host cell |
TWI480288B (zh) | 2010-09-23 | 2015-04-11 | Lilly Co Eli | 牛顆粒細胞群落刺激因子及其變體之調配物 |
CN102796197B (zh) * | 2011-05-24 | 2013-12-25 | 杭州九源基因工程有限公司 | 一种hsa-gcsf突变体及其制备方法 |
WO2013160895A1 (en) | 2012-04-24 | 2013-10-31 | Biokine Therapeutics Ltd. | Peptides and use thereof in the treatment of large cell lung cancer |
WO2015057724A1 (en) | 2013-10-14 | 2015-04-23 | Nora Therapeutics, Inc. | Use of g-csf for treating or preventing villitis of unknown etiology in a human female |
US10682390B2 (en) | 2015-07-16 | 2020-06-16 | Biokine Therapeutics Ltd. | Compositions and methods for treating cancer |
KR102033920B1 (ko) | 2016-02-23 | 2019-10-18 | 바이오라인알엑스 리미티드 | 급성 골수성 백혈병을 치료하는 방법 |
WO2023196818A1 (en) | 2022-04-04 | 2023-10-12 | The Regents Of The University Of California | Genetic complementation compositions and methods |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4810643A (en) * | 1985-08-23 | 1989-03-07 | Kirin- Amgen Inc. | Production of pluripotent granulocyte colony-stimulating factor |
DK203187A (da) * | 1986-04-22 | 1987-10-23 | Immunex Corp | Human g-csf proteinekspression |
US5214132A (en) * | 1986-12-23 | 1993-05-25 | Kyowa Hakko Kogyo Co., Ltd. | Polypeptide derivatives of human granulocyte colony stimulating factor |
NO176799C (no) * | 1986-12-23 | 1995-05-31 | Kyowa Hakko Kogyo Kk | DNA som koder for et polypeptid, rekombinant plasmid som koder for og kan uttrykke et polypeptid og fremgangsmåte for fremstilling av dette polypeptid |
WO1988008428A1 (en) * | 1987-04-28 | 1988-11-03 | Amgen Inc. | Method for purifying granulocyte/macrophage colony stimulating factor |
US4904584A (en) * | 1987-12-23 | 1990-02-27 | Genetics Institute, Inc. | Site-specific homogeneous modification of polypeptides |
JP2796388B2 (ja) * | 1988-05-13 | 1998-09-10 | アムジエン・インコーポレーテツド | G−csfの精製方法 |
EP0377023B1 (en) * | 1988-05-31 | 1995-02-15 | Cetus Oncology Corporation | Process for recovering refractile bodies containing heterologous proteins from microbial hosts |
US5218092A (en) * | 1988-09-29 | 1993-06-08 | Kyowa Hakko Kogyo Co., Ltd. | Modified granulocyte-colony stimulating factor polypeptide with added carbohydrate chains |
US5104651A (en) * | 1988-12-16 | 1992-04-14 | Amgen Inc. | Stabilized hydrophobic protein formulations of g-csf |
DE68925966T2 (de) * | 1988-12-22 | 1996-08-29 | Kirin Amgen Inc | Chemisch modifizierte granulocytenkolonie erregender faktor |
US5166322A (en) * | 1989-04-21 | 1992-11-24 | Genetics Institute | Cysteine added variants of interleukin-3 and chemical modifications thereof |
DE4014750A1 (de) * | 1990-05-08 | 1991-11-14 | Boehringer Mannheim Gmbh | Muteine des granulozyten-stimulierenden faktors (g-csf) |
-
1991
- 1991-04-12 GB GB919107846A patent/GB9107846D0/en active Pending
- 1991-04-26 AU AU76284/91A patent/AU644647B2/en not_active Ceased
- 1991-04-29 ZW ZW48/91A patent/ZW4891A1/xx unknown
- 1991-04-29 NO NO91911696A patent/NO911696L/no unknown
- 1991-04-29 DK DK91303868T patent/DK0459630T3/da active
- 1991-04-29 EP EP91303868A patent/EP0459630B1/en not_active Expired - Lifetime
- 1991-04-29 CA CA002041454A patent/CA2041454A1/en not_active Abandoned
- 1991-04-29 DE DE69129927T patent/DE69129927T2/de not_active Expired - Lifetime
- 1991-04-29 US US07/692,995 patent/US5416195A/en not_active Expired - Lifetime
- 1991-04-29 AT AT91303868T patent/ATE169336T1/de not_active IP Right Cessation
- 1991-04-29 ES ES91303868T patent/ES2118737T3/es not_active Expired - Lifetime
- 1991-04-29 IL IL97993A patent/IL97993A0/xx unknown
- 1991-04-29 IE IE144091A patent/IE911440A1/en unknown
- 1991-04-29 HU HU911440A patent/HUT60769A/hu unknown
- 1991-04-29 NZ NZ237974A patent/NZ237974A/xx unknown
- 1991-04-30 JP JP3228192A patent/JPH06100593A/ja active Pending
- 1991-04-30 PT PT97529A patent/PT97529A/pt not_active Application Discontinuation
- 1991-04-30 KR KR1019910006926A patent/KR910018406A/ko not_active Application Discontinuation
- 1991-04-30 CS CS911250A patent/CS125091A3/cs unknown
- 1991-04-30 TW TW080103367A patent/TW226022B/zh active
- 1991-04-30 FI FI912086A patent/FI912086A/fi unknown
-
1998
- 1998-08-06 GR GR980400784T patent/GR3027590T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
HUT60769A (en) | 1992-10-28 |
NO911696D0 (no) | 1991-04-29 |
DE69129927D1 (de) | 1998-09-10 |
ATE169336T1 (de) | 1998-08-15 |
IE911440A1 (en) | 1991-11-06 |
CA2041454A1 (en) | 1991-10-31 |
GB9107846D0 (en) | 1991-05-29 |
FI912086A (fi) | 1991-10-31 |
ES2118737T3 (es) | 1998-10-01 |
HU911440D0 (en) | 1991-11-28 |
JPH06100593A (ja) | 1994-04-12 |
FI912086A0 (fi) | 1991-04-30 |
US5416195A (en) | 1995-05-16 |
EP0459630A3 (en) | 1992-10-21 |
NO911696L (no) | 1991-10-31 |
AU7628491A (en) | 1991-11-14 |
DK0459630T3 (da) | 1999-05-03 |
EP0459630B1 (en) | 1998-08-05 |
GR3027590T3 (en) | 1998-11-30 |
PT97529A (pt) | 1992-01-31 |
AU644647B2 (en) | 1993-12-16 |
CS125091A3 (en) | 1992-02-19 |
EP0459630A2 (en) | 1991-12-04 |
ZW4891A1 (en) | 1992-01-01 |
DE69129927T2 (de) | 1999-04-01 |
NZ237974A (en) | 1993-09-27 |
KR910018406A (ko) | 1991-11-30 |
IL97993A0 (en) | 1992-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW226022B (zh) | ||
NO2003010I2 (no) | Pegfilgrastim | |
ATE93867T1 (de) | Rekombinante dns-vektoren faehig zur apoaequorinexpression, apoaequorinpeptide und deren herstellung und diese vektoren enthaltende mikroorganismen. | |
GB8912330D0 (en) | Live vaccines | |
PT90697A (pt) | Processo para a transformacao de uma celula hospedeira com um vector recombinante | |
SI0677584T1 (en) | Stable mutants of D-N-alpha-carbamylase | |
Camble et al. | Polypeptide derivatives of granulocyte colony stimulating factor | |
Ruppen et al. | Efficient expression of human growth hormone in Bacillus subtilis | |
ES8607390A1 (es) | Metodo de detectar acidos nucleicos. |